Enanta Pharmaceuticals
ENTA
ENTA
156 hedge funds and large institutions have $928M invested in Enanta Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 48 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $1.14B → $928M (-$209M)
26% less call options, than puts
Call options by funds: $2.32M | Put options by funds: $3.15M
42% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 33
Holders
156
Holding in Top 10
2
Calls
$2.32M
Puts
$3.15M
Top Buyers
| 1 | +$10.8M | |
| 2 | +$8.95M | |
| 3 | +$7.66M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.3M |
Top Sellers
| 1 | -$39.7M | |
| 2 | -$8.64M | |
| 3 | -$8.41M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.77M |
| 5 |
First Manhattan
New York
|
-$6.9M |